Colgate-palmolive Co. (CL)

$94.53

Market is closed - opens 7 PM, 17 May 2024

Insights on Colgate-palmolive Co.

  • Increasing Revenue

    Revenue is up for the last 7 quarters, 4.45B → 5.06B (in $), with an average increase of 2.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 718.0M → 683.0M (in $), with an average decrease of 4.9% per quarter

Performance

  • $94.14
    $94.81
    $94.53
    downward going graph

    0.41%

    Downside

    Day's Volatility :0.7%

    Upside

    0.29%

    downward going graph
  • $66.39
    $95.59
    $94.53
    downward going graph

    29.77%

    Downside

    52 Weeks Volatility :30.55%

    Upside

    1.11%

    downward going graph

Returns

PeriodColgate-palmolive Co.Sector (Consumer Staples)S&P500
3 Months
13.24%
5.5%
5.8%
6 Months
24.41%
11.2%
17.3%
1 Year
17.04%
1.4%
27.4%
3 Years
13.14%
9.2%
27.2%

Highlights

Market Capitalization
77.6B
Book Value
$0.28
Dividend Share
1.92
Dividend Yield
2.12%
Earnings Per Share (EPS)
3.15
PE Ratio
30.01
PEG Ratio
2.15
Wall Street Target Price
90.13
Profit Margin
13.22%
Operating Margin TTM
20.95%
Return On Assets TTM
15.71%
Return On Equity TTM
53.17%
Revenue TTM
19.8B
Revenue Per Share TTM
23.94
Quarterly Revenue Growth YOY
6.2%
Gross Profit TTM
10.2B
EBITDA
4.7B
Diluted Eps TTM
3.15
Quarterly Earnings Growth YOY
0.86
EPS Estimate Current Year
3.27
EPS Estimate Next Year
3.56
EPS Estimate Current Quarter
0.81
EPS Estimate Next Quarter
0.86

Analyst Recommendation

Buy
    62%Buy
    34%Hold
    3%Sell
Based on 29 Wall street analysts offering stock ratings for Colgate-palmolive Co.(by analysts ranked 0 to 5 stars)
Based on 29 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
17
16
Hold
10
12
14
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 2.91%

Current $94.53
Target $97.28

Company Financials

FY18Y/Y Change
Revenue
15.5B
↑ 0.58%
Net Income
2.4B
↑ 18.58%
Net Profit Margin
15.44%
↑ 2.34%
FY19Y/Y Change
Revenue
15.7B
↑ 0.96%
Net Income
2.4B
↓ 1.37%
Net Profit Margin
15.08%
↓ 0.36%
FY20Y/Y Change
Revenue
16.5B
↑ 4.96%
Net Income
2.7B
↑ 13.86%
Net Profit Margin
16.36%
↑ 1.28%
FY21Y/Y Change
Revenue
17.4B
↑ 5.77%
Net Income
2.2B
↓ 19.63%
Net Profit Margin
12.43%
↓ 3.93%
FY22Y/Y Change
Revenue
18.0B
↑ 3.13%
Net Income
1.8B
↓ 17.59%
Net Profit Margin
9.93%
↓ 2.5%
FY23Y/Y Change
Revenue
19.5B
↑ 8.29%
Net Income
2.3B
↑ 28.85%
Net Profit Margin
11.82%
↑ 1.89%
Q4 FY22Q/Q Change
Revenue
4.6B
↑ 3.91%
Net Income
43.0M
↓ 93.04%
Net Profit Margin
0.93%
↓ 12.94%
Q1 FY23Q/Q Change
Revenue
4.8B
↑ 3.05%
Net Income
372.0M
↑ 765.12%
Net Profit Margin
7.8%
↑ 6.87%
Q2 FY23Q/Q Change
Revenue
4.8B
↑ 1.09%
Net Income
502.0M
↑ 34.95%
Net Profit Margin
10.41%
↑ 2.61%
Q3 FY23Q/Q Change
Revenue
4.9B
↑ 1.93%
Net Income
708.0M
↑ 41.04%
Net Profit Margin
14.4%
↑ 3.99%
Q4 FY23Q/Q Change
Revenue
5.0B
↑ 0.71%
Net Income
718.0M
↑ 1.41%
Net Profit Margin
14.51%
↑ 0.11%
Q1 FY24Q/Q Change
Revenue
5.1B
↑ 2.32%
Net Income
683.0M
↓ 4.87%
Net Profit Margin
13.48%
↓ 1.03%
FY18Y/Y Change
Total Assets
12.2B
↓ 4.06%
Total Liabilities
12.0B
↓ 3.77%
FY19Y/Y Change
Total Assets
15.0B
↑ 23.62%
Total Liabilities
14.5B
↑ 21.0%
FY20Y/Y Change
Total Assets
15.9B
↑ 5.89%
Total Liabilities
14.8B
↑ 2.37%
FY21Y/Y Change
Total Assets
15.0B
↓ 5.53%
Total Liabilities
14.1B
↓ 5.06%
FY22Y/Y Change
Total Assets
15.7B
↑ 4.59%
Total Liabilities
14.9B
↑ 6.08%
FY23Y/Y Change
Total Assets
16.4B
↑ 4.21%
Total Liabilities
15.4B
↑ 3.42%
Q4 FY22Q/Q Change
Total Assets
15.7B
↓ 3.42%
Total Liabilities
14.9B
↓ 2.03%
Q1 FY23Q/Q Change
Total Assets
16.2B
↑ 2.81%
Total Liabilities
15.7B
↑ 5.51%
Q2 FY23Q/Q Change
Total Assets
16.2B
↑ 0.33%
Total Liabilities
15.9B
↑ 1.04%
Q3 FY23Q/Q Change
Total Assets
16.0B
↓ 1.13%
Total Liabilities
15.6B
↓ 1.73%
Q4 FY23Q/Q Change
Total Assets
16.4B
↑ 2.18%
Total Liabilities
15.4B
↓ 1.29%
Q1 FY24Q/Q Change
Total Assets
16.6B
↑ 1.09%
Total Liabilities
16.0B
↑ 3.36%
FY18Y/Y Change
Operating Cash Flow
3.1B
↑ 0.07%
Investing Cash Flow
-1.2B
↑ 148.41%
Financing Cash Flow
-2.7B
↑ 9.35%
FY19Y/Y Change
Operating Cash Flow
3.1B
↑ 2.52%
Investing Cash Flow
-2.1B
↑ 79.4%
Financing Cash Flow
-870.0M
↓ 67.53%
FY20Y/Y Change
Operating Cash Flow
3.7B
↑ 18.7%
Investing Cash Flow
-779.0M
↓ 62.89%
Financing Cash Flow
-2.9B
↑ 235.52%
FY21Y/Y Change
Operating Cash Flow
3.3B
↓ 10.59%
Investing Cash Flow
-592.0M
↓ 24.01%
Financing Cash Flow
-2.8B
↓ 4.97%
FY22Y/Y Change
Operating Cash Flow
2.6B
↓ 23.13%
Investing Cash Flow
-1.6B
↑ 170.44%
Financing Cash Flow
-952.0M
↓ 65.68%
Q4 FY22Q/Q Change
Operating Cash Flow
673.0M
↓ 30.55%
Investing Cash Flow
-1.6B
↑ 12.11%
Financing Cash Flow
-666.0M
↓ 772.73%
Q1 FY23Q/Q Change
Operating Cash Flow
735.0M
↑ 9.21%
Investing Cash Flow
-264.0M
↓ 83.51%
Financing Cash Flow
-375.0M
↓ 43.69%
Q2 FY23Q/Q Change
Operating Cash Flow
722.0M
↓ 1.77%
Investing Cash Flow
-174.0M
↓ 34.09%
Financing Cash Flow
-580.0M
↑ 54.67%
Q3 FY23Q/Q Change
Operating Cash Flow
1.2B
↑ 59.56%
Investing Cash Flow
-599.0M
↑ 244.25%
Financing Cash Flow
-846.0M
↑ 45.86%

Technicals Summary

Sell

Neutral

Buy

Colgate-palmolive Co. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Colgate-palmolive Co.
Colgate-palmolive Co.
9.7%
24.41%
17.04%
13.14%
30.39%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
-0.68%
10.91%
-30.24%
-54.15%
-20.33%
Procter & Gamble Company, The
Procter & Gamble Company, The
6.77%
8.95%
6.92%
20.9%
54.02%
Kenvue Inc.
Kenvue Inc.
6.59%
4.37%
-24.54%
-23.64%
-23.64%
Kimberly-clark Corp.
Kimberly-clark Corp.
7.05%
10.65%
-7.41%
0.36%
4.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Colgate-palmolive Co.
Colgate-palmolive Co.
30.02
30.02
2.15
3.53
0.53
0.16
0.02
0.28
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
75.31
75.31
1.6
2.22
0.1
0.03
0.02
16.02
Procter & Gamble Company, The
Procter & Gamble Company, The
27.09
27.09
3.28
6.55
0.32
0.11
0.02
20.87
Kenvue Inc.
Kenvue Inc.
26.42
26.42
2.11
1.14
0.1
0.06
0.04
5.55
Kimberly-clark Corp.
Kimberly-clark Corp.
24.79
24.79
1.57
7.12
1.81
0.11
0.04
3.1
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$77.6B
30.39%
30.02
13.22%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Buy
$48.3B
-20.33%
75.31
4.18%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$391.2B
54.02%
27.09
17.99%
Kenvue Inc.
Kenvue Inc.
Buy
$39.5B
-23.64%
26.42
9.63%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$45.5B
4.02%
24.79
9.05%

Institutional Holdings

  • Vanguard Group Inc

    9.74%

  • BlackRock Inc

    6.85%

  • State Street Corporation

    5.80%

  • T. Rowe Price Associates, Inc.

    3.92%

  • Wellington Management Company LLP

    3.50%

  • Morgan Stanley - Brokerage Accounts

    2.37%

Corporate Announcements

  • Colgate-palmolive Co. Dividends March,2024

    In the quarter ending March,2024. Colgate-palmolive Co. has declared dividend of $0.48

    Read More

Company Information

every day, millions of consumers around the world trust our products to care for themselves and the ones they love. colgate-palmolive is a global company serving people in over 200 countries and territories with consumer products that make their lives healthier and more enjoyable. colgate manufactures and markets oral care, personal care, home care and pet nutrition products under such internationally recognized brand names as colgate, palmolive, speed stick, lady speed stick, softsoap, irish spring, protex, sorriso, kolynos, elmex, tom’s of maine, sanex, ajax, axion, fabuloso, soupline and suavitel, as well as hill’s science diet, hill’s prescription diet and hill’s ideal balance. follow @cp_news on twitter for news about colgate-palmolive: https://twitter.com/cp_news for information about joining our team, visit https://jobs.colgate.com/ and stay connected at: http://facebook.com/colgatepalmolivejobs https://twitter.com/colgatecareers

Organization
Colgate-palmolive Co.
Employees
34000
CEO
Mr. Noel R. Wallace
Industry
Consumer Non-Durables

Discover More

FAQs